Thrombosis and Hemostasis Issues in Cancer - Second International Conference. 19-21 September, 2003, Bergamo, Italy.
Vermont and Dartmouth Medical School, HB 7900, Lebanon, NH 03755, USA. leo.r.zacharski@dartmouth.edu
Leo R
LR
Zacharski
D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use*; D001384:Azetidines / Q000737:chemistry / Q000627:therapeutic use; D001596:Benzylamines; D001779:Blood Coagulation Factors / Q000502:physiology; D002986:Clinical Trials as Topic; D004730:Endothelium, Vascular / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000737:chemistry / Q000627:therapeutic use*; D000077425:Fondaparinux; D006487:Hemostasis; D006801:Humans; D009369:Neoplasms / Q000097:blood* / Q000098:blood supply / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D009844:Oligosaccharides / Q000737:chemistry / Q000627:therapeutic use; D011134:Polysaccharides / Q000737:chemistry / Q000627:therapeutic use; D013267:Stilbenes / Q000737:chemistry / Q000627:therapeutic use; D013927:Thrombosis / Q000097:blood* / Q000188:drug therapy
D000970:Antineoplastic Agents; D001384:Azetidines; D001596:Benzylamines; D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents; D009844:Oligosaccharides; D011134:Polysaccharides; D013267:Stilbenes; C426686:ximelagatran; C479958:idraparinux; C058728:fosbretabulin; D000077425:Fondaparinux